Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Shackleton

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Science Translational Medicine|November 9, 2012
Human melanoma metastasis in NSG mice correlates with clinical outcome in patientsElsa Quintana, Elena Piskounova, Mark Shackleton, et al.
Journal of Surgical Oncology|June 18, 2015
Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indicationMike He, Jane Lovell, Bee Ling Ng, et al.
Cancer Cell|November 16, 2010
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organizedElsa Quintana, Mark Shackleton, Hannah R Foster, et al.
Journal for Immunotherapy of Cancer|October 9, 2025
Expansion of a circulating Ki67-positive effector T-cell population following combined PD-1 and CTLA-4 blockade for melanoma is predictive of treatment responseJack M Edwards, Sashendra Senthi, Robin Smith, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 21, 2009
Impaired lactation in mice expressing dominant-negative FADD in mammary epitheliumMark Shackleton, Lorraine A O'Reilly, Kate D Sutherland, et al.
Cell Death & Disease|April 5, 2022
Removal of BFL-1 sensitises some melanoma cells to killing by BH3 mimetic drugsLahiru Gangoda, Robyn L Schenk, Lin Tai, et al.
Pigment Cell & Melanoma Research|June 30, 2025
Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease PropagationClare Fedele, Gamze Kuser-Abali, Ralph Rossi, et al.
Plos One|June 6, 2012
Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumorsAnjali Tikoo, Vincent Roh, Karen G Montgomery, et al.
Bioinformatics (Oxford, England)|January 7, 2014
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped readsJan Schröder, Arthur Hsu, Samantha E Boyle, et al.
Journal of the National Cancer Institute|July 20, 2006
Steroid hormone receptor status of mouse mammary stem cellsMarie-Liesse Asselin-Labat, Mark Shackleton, John Stingl, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Science Translational Medicine|November 9, 2012
Human melanoma metastasis in NSG mice correlates with clinical outcome in patientsElsa Quintana, Elena Piskounova, Mark Shackleton, et al.
Journal of Surgical Oncology|June 18, 2015
Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indicationMike He, Jane Lovell, Bee Ling Ng, et al.
Cancer Cell|November 16, 2010
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organizedElsa Quintana, Mark Shackleton, Hannah R Foster, et al.
Journal for Immunotherapy of Cancer|October 9, 2025
Expansion of a circulating Ki67-positive effector T-cell population following combined PD-1 and CTLA-4 blockade for melanoma is predictive of treatment responseJack M Edwards, Sashendra Senthi, Robin Smith, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 21, 2009
Impaired lactation in mice expressing dominant-negative FADD in mammary epitheliumMark Shackleton, Lorraine A O'Reilly, Kate D Sutherland, et al.
Cell Death & Disease|April 5, 2022
Removal of BFL-1 sensitises some melanoma cells to killing by BH3 mimetic drugsLahiru Gangoda, Robyn L Schenk, Lin Tai, et al.
Pigment Cell & Melanoma Research|June 30, 2025
Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease PropagationClare Fedele, Gamze Kuser-Abali, Ralph Rossi, et al.
Plos One|June 6, 2012
Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumorsAnjali Tikoo, Vincent Roh, Karen G Montgomery, et al.
Bioinformatics (Oxford, England)|January 7, 2014
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped readsJan Schröder, Arthur Hsu, Samantha E Boyle, et al.
Journal of the National Cancer Institute|July 20, 2006
Steroid hormone receptor status of mouse mammary stem cellsMarie-Liesse Asselin-Labat, Mark Shackleton, John Stingl, et al.
Pageof 10